About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Longitudinal Study of Cell Free DNA in Lung Transplant

NCT04234919·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Colorado, Denver

With

CareDx

Age

18–99

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

≥ 18 years old
Actively listed or have recently had a double lung transplant
Participant is willing and able to provide informed consent

You may not be if

Prior organ transplantation
Transplantation performed in the setting of hospitalization for acute illness or decompensation
Unable or unwilling to consent for enrolment
Single lung transplant recipient
Consideration for multi-organ transplantation
Pregnant women

The record

StatusCompleted

PhaseNo phase

Taking part24

StartedMar 2020

UpdatedNov 2, 2022

Conditions

Lung Transplant Rejection

Where1

University of Colorado, Denver
Aurora, Colorado, United States

Clareo Health | Longitudinal Study of Cell Free DNA in Lung Transplant